Exodus Point Capital Management, LP Karuna Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

  • $13.1 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023
BUY
$164.66 - $218.08 $1.69 Million - $2.24 Million
10,279 Added 44.63%
33,311 $5.63 Million
Q2 2023

Aug 10, 2023
BUY
$176.32 - $240.22 $4.06 Million - $5.53 Million
23,032 New
23,032 $4.99 Million
Q3 2022

Nov 10, 2022
SELL
$123.79 - $277.42 $912,084 - $2.04 Million
-7,368 Closed
0 $0
Q2 2022

Aug 19, 2022
BUY
$93.97 - $143.33 $692,370 - $1.06 Million
7,368 New
7,368 $932,000

Others Institutions Holding KRTX

# of Institutions
13
Shares Held
333K
Call Options Held
0
Put Options Held
0
View Full List

About Karuna Therapeutics, Inc.

KRTX Quotes by TradingView
  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email